Howard J. Jacob to Deliver Daniel T. O’Connor Memorial Lecture February 23

Dr. Howard J. Jacob will present the Daniel T. O’Connor 2nd Annual Memorial Lecture on Thursday, February 23, 2017, at UC San Diego School of Medicine. His topic is “From Hypertension to Genomic Medicine.”

Dr. Jacob’s lecture will take place in the Leichtag Auditorium (Room 107), with a reception immediately following on the patio.

Dr. Jacob is Executive Vice President for Medical Genomics, Chief Medical Genomics Officer, and Faculty Investigator at HudsonAlpha Institute for Biotechnology. His UC San Diego hosts are Bruce A. Hamilton, PhD, and Nicholas J. Schork, PhD.

Dr. Hamilton is Professor, Cellular and Molecular Medicine, Department of Medicine; Director, Genetics Training Program; and Associate Director, Institute for Genomic Medicine. Dr. Schork is UC San Diego Adjunct Professor, Psychiatry, Family and Preventive Medicine and Director of Human Biology, J. Craig Venter Institute.

The lecture is presented in conjunction with the UC San Diego CTRI Seminar Series and the Genetics, Bioinformatics and Systems Biology Colloquium Series.

Dr. Karl Hostetler on Discovery and Development of Brincidofovir (DNA Viruses) and 1968(HPV 16&18) October 1

Dr. Karl HostetlerDr. Karl Hostetler presents on the topic, “Discovery and Development of Brincidofovir (DNA Viruses) and 1968 (HPV 16&18)” at Medicine Grand Rounds on October 1.

Karl Hostetler, MD, is emeritus professor of medicine in the Division of Infectious Diseases at UC San Diego.

UC Medical Campus Consortium Named Designated Center to Translate Innovations into Improved Health

A consortium of the five University of California medical campuses at UC San Diego, UC Davis, UC Irvine, UCLA and UC San Francisco has been designated a Center for Accelerated Innovations by the National Heart, Lung and Blood Institute (NHLBI). The designation, among the first of its kind from NHLBI, recognizes the University of California’s potential to translate its leading-edge discoveries into innovative products that benefit patients. … Read the full story from the UCSD Newsroom


Dr. Gary FiresteinGary S. Firestein, MD, chair of the UC BRAID consortium that will oversee the new UC Center for Accelerated Innovations, is dean and associate vice chancellor of translational medicine at UC San Diego Health Sciences

He led UC San Diego’s successful effort to win a Clinical and Translational Science Award in 2010 and is the founding director of the UC San Diego Clinical and Translational Research Institute.

Firestein is professor of medicine and former chief of the Division of Rheumatology, Allergy & Immunology at UC San Diego. He served as division chief from 1998 until he stepped down in 2010 to devote full time to his activities as dean of translational medicine.

In 2011, philanthropists Lisa and Steve Altman made a major gift to the planned Clinical and Translational Research building on the La Jolla campus of UC San Diego Health System. Construction started in early 2013 and the building, named the Altman Clinical and Translational Research Institute, is scheduled to open in 2016.

UC San Diego Health System Video: The Altman Clinical and Translational Research Institute

More Information:

Study Finds Potential New Drug Therapy for Crohn’s Disease

Ustekinumab Induces, Sustains Clinical Response in Patients

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn’s Disease, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the October 18, 2012 issue of the New England Journal of MedicineRead the full story from the UCSD Newsroom


Dr. William J. SandbornThe principal investigator of the study is Dr. William J. Sandborn, professor of medicine and chief of the Division of Gastroenterology at UCSD.  |  Read his academic profile  |  Read his clinical profile

Read the report of the study in the New England Journal of Medicine (full text UCSD only)

Citation of study report:  Sandborn WJ, Gasink C, Gao L-L, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P,  Ghosh S, de Villiers WJS, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG for the CERTIFI Study Group. N Engl J Med 2012; 367:1519-1528 October 18, 2012 DOI: 10.1056/NEJMoa1203572

Non-human Sugar in Biotech Drugs Causes Inflammation

New research findings from Dr. Ajit Varki and colleagues are the subject of the UCSD Newsroom story, “Non-human Sugar in Biotech Drugs Causes Inflammation.”

Ajit Varki, M.D., is Professor of Medicine in the Division of Hematology-Oncology and Professor in the Department of Cellular and Molecular Medicine. He co-directs the UC San Diego Glycobiology Research and Training Center and the UC San Diego/Salk Center for Academic Research and Training in Anthropogeny (CARTA). He is Associate Dean of the Physician-Scientist Training Program.